Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:04:55.543Z.
Calculation as of: 2026-10-06T18:04:55.543Z.
Quote observation: 2026-10-06T18:00:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dfe3b7eb0a07bb41d8210bce1124860262d7a4d6e18a93ea2ad6da4bd4c55c28
EARNINGS YIELD
N/A
Praxis Precision Medicines, Inc.
Market Cap
$7.68B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.62B
Earnings Yield
N/A
TTM Avg
2.30%
3Y Avg
2.30%
5Y Avg
2.30%
Market Cap
$7.89B
Earnings Yield
1.28%
TTM Avg
1.38%
3Y Avg
1.38%
5Y Avg
1.38%
Market Cap
$7.97B
Earnings Yield
5.26%
TTM Avg
6.84%
3Y Avg
3.59%
5Y Avg
3.59%
Market Cap
$7.32B
Earnings Yield
N/A
TTM Avg
2.04%
3Y Avg
3.02%
5Y Avg
2.45%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. (PRAX) | $7.68B | N/A | N/A | N/A | N/A |
| Cytokinetics, Incorporated (CYTK)vs › | $7.62B | N/A | 2.30% | 2.30% | 2.30% |
| HealthEquity, Inc. (HQY)vs › | $7.61B | 3.04% | 2.61% | 1.55% | 1.43% |
| Hinge Health, Inc. (HNGE)vs › | $7.56B | 1.32% | 1.41% | 2.92% | 2.92% |
| Caris Life Sciences, Inc. (CAI)vs › | $7.89B | 1.28% | 1.38% | 1.38% | 1.38% |
| TG Therapeutics, Inc. (TGTX)vs › | $7.97B | 5.26% | 6.84% | 3.59% | 3.59% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.32B | N/A | 2.04% | 3.02% | 2.45% |
| Oscar Health, Inc. (OSCR)vs › | $8.36B | 4.34% | 4.52% | 2.80% | 2.80% |
| Alkermes plc (ALKS)vs › | $7.00B | 0.92% | 4.07% | 5.88% | 5.64% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.58B | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
